Subscribe To
Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting
PHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that Samik Basu, M.D., Chief Scientific Officer at Cabaletta Bio, will deliver an invited, oral presentation titled “CD 19 CAR T-cells […] The post Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting app...
Read More
Posted: May 2 2023, 20:35
Author Name: forextv
Views: 110926